Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium thiosulfate for vascular calcification and pruritus in hemodialysis patients with uremia
ChiCTR2200062894Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sodium thiosulfate in uremia (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoints: Coronary artery calcification score and Duo's modified pruritus score. Started Oct 2022; status: recruiting.
02
Drugs
sodium thiosulfate
03
Conditions
uremia
Beyond the preview
Go deeper on ChiCTR2200062894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062894.